MedTrace Logo

Leukapheresis to Obtain Lymphocytes for Studies on Antiretroviral Naive HIV-infected Patients

NCT00333892 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2012-06-05

No results posted yet for this study

Summary

To further investigate differences in the immunologic function of various lymphocyte subsets in HIV-infected patients who are treated early in their infection and during the chronic phase of the infection. Studies will also be done to further delineate the various antigen-specific and innate immune responses including characterization of soluble factors associated with primary HIV infection.

Conditions

  • Human Immunodeficiency Virus

Interventions

PROCEDURE

leukapheresis

pack of cells as per protocol

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • Canadian Immunodeficiency Research Collaborative

    lead OTHER

Principal Investigators

  • Mario Ostrowski, MD · University of Toronto

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-08-31
Completion
2008-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00333892 on ClinicalTrials.gov